Frontiers | CD5, an Undercover Regulator of TCR Signaling
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy
Circulating T cell-monocyte complexes are markers of immune perturbations | eLife
T-cell therapies for T-cell lymphoma - Cytotherapy
Naïve helper T cells with high CD5 expression have increased calcium signaling | PLOS ONE
CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation | PNAS
CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation | PNAS
A Guide to B Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library
Effect of CD5 enhancer deletion on CD5 expression on splenic T cells.... | Download Scientific Diagram
VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance | Science
CD5 on dendritic cells regulates CD4+ and CD8+ T cell activation and induction of immune responses | PLOS ONE
Comprehensive Phenotyping of T Cells Using Flow Cytometry - Mousset - 2019 - Cytometry Part A - Wiley Online Library
Expression of T cell surface markers on CD5 KO and WT mouse TIL. A, TIL... | Download Scientific Diagram
Regulation of B-1 B cell activation. (1 and 2) CD5 mediated... | Download Scientific Diagram
Pan T cells (human) | Human cell types | Human cells and organs | MACS Handbook | Resources | Miltenyi Biotec | USA
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library
Antigen-inexperienced memory CD8+ T cells: where they come from and why we need them | Nature Reviews Immunology
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti- CD5 CAR T Cells | SpringerLink
Cells | Free Full-Text | Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy
CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology
Frontiers | CD5, an Undercover Regulator of TCR Signaling
Effects of CD5 on different stages of T cell development. CD5... | Download Scientific Diagram
Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines. - Abstract - Europe PMC
